International Clinical Trial: Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07119021) titled 'Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)' on Aug. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Ruijun Ji

Condition: Ischemic Stroke

Intervention: Drug: Intravenous thrombolysis + edaravone

Recruitment Status: Recruiting

Phase: Phase 4

Date of First Enrollment: August 1, 2024

Target Sample Size: 300

Countries of...